Abiopharma

🔍 Donnley Deneen L (Director)

Company: Piedmont Realty Trust, Inc. (PDM)

Report Date: 2026-05-12

Detailed Transactions and Holdings:

• Acquired 15,217 shares of Common Stock (Direct)
  Date: 2026-05-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,529.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 15,217 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-12 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 12,883 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,883.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of PDM common stock. Restricted stock units may be settled in cash or common stock at PDM's election.
• F2: On May 15, 2025, at the 2025 Annual Meeting of Stockholders of Piedmont Realty Trust, Inc., the reporting person was granted 15,217 restricted stock units, which vested at the 2026 Annual Meeting of Stockholders on May 12, 2026, and was settled in PDM common stock.
• F3: On May 12, 2026, at the 2026 Annual Meeting of Stockholders of Piedmont Realty Trust, Inc., the reporting person was granted 12,883 restricted stock units, which will vest on the earlier of the 2027 Annual Meeting of Stockholders, or the anniversary of the grant date in May 2027.